Lars L. Gullestad
Expertise in
16
conditions

Lars L. Gullestad

Oslo, NO 
Expertise in
16
conditions
Oslo, NO 

Overview

Lars Gullestad practices practicing medicine in Oslo, Norway.

Mr. Gullestad is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Heart Failure, Aortic Valve Stenosis, Aortic Regurgitation, Heart Transplant, and Lung Transplant.

He is actively involved in clinical research, co-authoring 296 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Oslo, Norway
Other Locations
Nydalen, 0424, Norway
Blindern, 0316, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis: The IIISAS Trial
Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis: The IIISAS Trial
Enrollment Status: Completed
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drug: Iron Isomaltoside
Study Phase: Phase 2
Sleep Disordered Breathing in Patients With Paroxysmal Atrial Fibrillation
Sleep Disordered Breathing in Patients With Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: June 22, 2021
Intervention Type: Device
Study Phase: Not Applicable
High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
Enrollment Status: Completed
Publish Date: December 09, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
5, 6 or 7 Year Follow-up Control After the SCHEDULE Study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE)
5, 6 or 7 Year Follow-up Control After the SCHEDULE Study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE)
Enrollment Status: Completed
Publish Date: October 03, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

296 Total Publications

Anticoagulation Monotherapy vs Antiplatelet Monotherapy After Transcatheter Aortic Valve Implant: The ACASA-TAVI Randomized Clinical Trial.
Anticoagulation Monotherapy vs Antiplatelet Monotherapy After Transcatheter Aortic Valve Implant: The ACASA-TAVI Randomized Clinical Trial.
Journal: JAMA
Published: August 30, 2026

Frequently Asked Questions about Lars L. Gullestad

Is Lars L. Gullestad a top-rated expert for Heart Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Lars L. Gullestad is classified as an Elite expert for Heart Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lars L. Gullestad participate in research or clinical trials?

Yes. Lars L. Gullestad has published 296 articles and abstracts on conditions like Heart Transplant. You can view a list of Lars L. Gullestad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gullestad's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile